Purchases and Sales Made in Q1 2023 in Editas Medicine, Inc. (EDIT)
This table provides information about the institutional ownership of Editas Medicine, Inc. (EDIT) during Q1 2023. The information is specifically focused on institutions that hold shares of Editas Medicine, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Apr 24, 2023
Q1 2023
|
Imc Chicago, LLC
|
SELL
|
- |
-34.1KClosed |
$240K - $393K
|
0
$0
|
|
|
May 12, 2023
Q1 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-38.3K- 2.32% |
$269K - $441K
|
1.61M
$3.48M
|
|
|
May 15, 2023
Q1 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-51.3K- 69.79% |
$360K - $591K
|
22.2K
$47.9K
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-56.9K- 20.91% |
$400K - $656K
|
215K
$465K
|
|
|
May 15, 2023
Q1 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-58.3K- 22.36% |
$410K - $672K
|
202K
$437K
|
|
|
May 15, 2023
Q1 2023
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-78.2K- 71.35% |
$550K - $902K
|
31.4K
$67.8K
|
|
|
May 11, 2023
Q1 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-86.6K- 11.23% |
$609K - $998K
|
684K
$1.48M
|
|
|
May 15, 2023
Q1 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-136K- 69.89% |
$954K - $1.57M
|
58.5K
$126K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-136K- 11.53% |
$958K - $1.57M
|
1.05M
$2.26M
|
|
|
May 15, 2023
Q1 2023
|
Capital Fund Management S.A.
Paris, I0 |
SELL
|
- |
-143K- 37.37% |
$1M - $1.65M
|
239K
$517K
|
|
|
May 15, 2023
Q1 2023
|
Edgestream Partners, L.P.
Princeton, NJ |
SELL
|
- |
-144K- 48.21% |
$1.01M - $1.66M
|
155K
$334K
|
|
|
May 04, 2023
Q1 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-165K- 37.53% |
$1.16M - $1.91M
|
275K
$594K
|
|
|
May 15, 2023
Q1 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-195K- 17.75% |
$1.37M - $2.24M
|
901K
$1.95M
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-196K- 21.74% |
$1.38M - $2.26M
|
706K
$1.53M
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-196K- 21.74% |
$1.38M - $2.26M
|
706K
$1.53M
|
|
|
May 15, 2023
Q1 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-207K- 30.03% |
$1.46M - $2.39M
|
483K
$1.04M
|
|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-244K- 25.6% |
$1.71M - $2.81M
|
709K
$1.53M
|
|
|
May 15, 2023
Q1 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-426K- 29.04% |
$2.99M - $4.91M
|
1.04M
$2.25M
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-859K- 40.07% |
$6.04M - $9.9M
|
1.28M
$2.77M
|
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.06M- 11.47% |
$7.44M - $12.2M
|
8.16M
$17.6M
|